Fusion proteins for the treatment of CNS

Details for Australian Patent Application No. 2004247025 (hide)

Owner Acorda Therapeutics, Inc.

Inventors Roy, Gargi; Caggiano, Anthony O.; Iaci, Jennifer; Gruskin, Elliott A.; Zimber, Michael P.

Agent Pizzeys

Pub. Number AU-B-2004247025

PCT Pub. Number WO2004/110359

Priority 60/471,239 16.05.03 US; 60/471,236 16.05.03 US; 60/471,300 16.05.03 US; 60/474,372 29.05.03 US

Filing date 17 May 2004

Wipo publication date 23 December 2004

Acceptance publication date 23 June 2011

International Classifications

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

A61K 31/00 (2006.01)

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/110359 Priority application(s): WO2004/110359

8 December 2005 Amendment Made

  The nature of the amendment is: Add priority details 60/471.240 16 May 2003 US 2004251040 University of Utah Research Foundation The nature of the amendment is: Amend the invention title to read Anti-adhesion composites and methods of use thereof 2004251042 Depuy Spine, Inc. The nature of the amendment is as shown in the statement(s) filed 09 Nov 2005

23 June 2011 Application Accepted

  Published as AU-B-2004247025

30 June 2011 Corrigenda

  Applications Accepted - Name Index Under the name Acorda Therapeutics, Inc., Application No. 2004247025, under INID (31) insert 60/471,240, under INID insert 16 May 2003, under INID insert US

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247026-Proteoglycan degrading mutants for treatment of CNS

2004247023-Heterocyclic compounds and uses thereof